Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 54.48 USD -0.62% Market Closed
Market Cap: 12.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+28%
Revenue
Forecast
+4%
Operating Income
Forecast
+14%
Net Income
Forecast
+13%

Wall Street
Price Targets

HOLX Price Targets Summary
Hologic Inc

Wall Street analysts forecast HOLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HOLX is 69.73 USD with a low forecast of 60.6 USD and a high forecast of 89.25 USD.

HOLX Lowest Forecast
Wall Street Target
60.6 USD
11% Upside
HOLX Average Forecast
Wall Street Target
69.73 USD
28% Upside
HOLX Highest Forecast
Wall Street Target
89.25 USD
64% Upside
Lowest
Price Target
60.6 USD
11% Upside
Average
Price Target
69.73 USD
28% Upside
Highest
Price Target
89.25 USD
64% Upside
Hologic Inc Competitors:
Price Targets
STE
STERIS plc
6% Upside
GEHC
GE Healthcare Technologies Inc
30% Upside
ATEC
Alphatec Holdings Inc
49% Upside
LMAT
LeMaitre Vascular Inc
35% Upside
STE
STERIS plc
6% Upside
GEHC
GE Healthcare Technologies Inc
30% Upside
ATEC
Alphatec Holdings Inc
49% Upside
LMAT
LeMaitre Vascular Inc
35% Upside
C
214150
Classys Inc
23% Upside
BSX
Boston Scientific Corp
15% Upside
S
STXS
Stereotaxis Inc
127% Upside
IDXX
IDEXX Laboratories Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Hologic Inc

For the last 8 years the compound annual growth rate for Hologic Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

5%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Hologic Inc

For the last 8 years the compound annual growth rate for Hologic Inc's operating income is 7%. The projected CAGR for the next 3 years is 14%.

7%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Hologic Inc

For the last 8 years the compound annual growth rate for Hologic Inc's net income is 11%. The projected CAGR for the next 3 years is 13%.

11%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
HOLX intrinsic value, competitors valuation, and company profile.
DCF Valuation
HOLX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HOLX stock valuation using valuation multiples.
Wall Street Estimates
HOLX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HOLX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HOLX's stock price target?
Price Target
69.73 USD

According to Wall Street analysts, the average 1-year price target for HOLX is 69.73 USD with a low forecast of 60.6 USD and a high forecast of 89.25 USD.

What is Hologic Inc's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Hologic Inc's revenue is 5%. The projected CAGR for the next 3 years is 4%.

What is Hologic Inc's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Hologic Inc's operating income is 7%. The projected CAGR for the next 3 years is 14%.

What is Hologic Inc's Net Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Hologic Inc's net income is 11%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.